본문 바로가기
KERD
논문KCI 등재

Synaptotagmin-4 induces anhedonic responses to chronic stress via BDNF signaling in the medial prefrontal cortex

0

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Stressful circumstances are significant contributors to mental illnesses such as major depressive disorder. Anhedonia, defined as loss of the ability to enjoy pleasure in pleasurable situations, including rewarding activities or social contexts, is considered a key symptom of depression. Although stress-induced depression is associated with anhedonia in humans and animals, the underlying molecular mechanisms of anhedonic responses remain poorly understood. In this study, we demonstrated that synaptotagmin-4 (SYT4), which is involved in the release of neurotransmitters and neurotrophic factors, is implicated in chronic stress-induced anhedonia. Employing chronic unpredictable stress (CUS), we evaluated two subpopulations of mice, susceptible (SUS, anhedonic) and resilient (RES, nonanhedonic), based on sucrose preference, which was strongly correlated with social reward. The FosTRAP (targeted recombination in active populations) system and optogenetic approach revealed that neural activity in the medial prefrontal cortex (mPFC) was significantly associated with CUS-induced anhedonic behavioral phenotypes. By conducting weighted gene coexpression network analysis of RNA sequencing data from the mPFC of SUS and RES mice, we identified Syt4 as a hub gene in a gene network that was unique to anhedonia. We also confirmed that Syt4 overexpression in the mPFC was pro-susceptible, while Syt4 knockdown was pro-resilient; the pro-susceptible effects of SYT4 were mediated through a reduction in brain-derived neurotrophic factor (BDNF)-tropomyosin receptor kinase B (TrkB) signaling in the mPFC. These findings suggest that SYT4-BDNF interactions in the mPFC represent a crucial regulatory mechanism of anhedonic susceptibility to chronic stress.

Abstract

Stressful circumstances are significant contributors to mental illnesses such as major depressive disorder. Anhedonia, defined as loss of the ability to enjoy pleasure in pleasurable situations, including rewarding activities or social contexts, is considered a key symptom of depression. Although stress-induced depression is associated with anhedonia in humans and animals, the underlying molecular mechanisms of anhedonic responses remain poorly understood. In this study, we demonstrated that synaptotagmin-4 (SYT4), which is involved in the release of neurotransmitters and neurotrophic factors, is implicated in chronic stress-induced anhedonia. Employing chronic unpredictable stress (CUS), we evaluated two subpopulations of mice, susceptible (SUS, anhedonic) and resilient (RES, nonanhedonic), based on sucrose preference, which was strongly correlated with social reward. The FosTRAP (targeted recombination in active populations) system and optogenetic approach revealed that neural activity in the medial prefrontal cortex (mPFC) was significantly associated with CUS-induced anhedonic behavioral phenotypes. By conducting weighted gene coexpression network analysis of RNA sequencing data from the mPFC of SUS and RES mice, we identified Syt4 as a hub gene in a gene network that was unique to anhedonia. We also confirmed that Syt4 overexpression in the mPFC was pro-susceptible, while Syt4 knockdown was pro-resilient; the pro-susceptible effects of SYT4 were mediated through a reduction in brain-derived neurotrophic factor (BDNF)-tropomyosin receptor kinase B (TrkB) signaling in the mPFC. These findings suggest that SYT4-BDNF interactions in the mPFC represent a crucial regulatory mechanism of anhedonic susceptibility to chronic stress.

참고문헌 (68)

  1. Guajardo, V. D., "Loss of interest, depressed mood and impact on the quality of life : cross-sectional survey", BMC Public Health, 11, pp.826~ (2011)
  2. Malhi, G. S., "Depression", Lancet, 392, pp.2299~2312 (2018)
  3. Kerns, J. G., "Social and physical anhedonia and valence and arousal aspects of emotional experience", J Abnorm Psychol, 117, pp.735~746 (2008)
  4. Kollias, C. T., "Association of physical and social anhedonia with depression in the acute phase of schizophrenia", Psychopathology, 41, pp.365~370 (2008)
  5. McMakin, D. L., "Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression", J Am Acad Child Adolesc Psychiatry, 51, pp.404~411 (2012)
  6. Treadway, M. T., "Reconsidering anhedonia in depression : lessons from translational neuroscience", Neurosci Biobehav Rev, 35, pp.537~555 (2011)
  7. Rubin, D. H., "Joy returns last : anhedonia and treatment resistance in depressed adolescents", J Am Acad Child Adolesc Psychiatry, 51, pp.353~355 (2012)
  8. Cipriani, A., "Suicide, depression, and antidepressants", BMJ, 330, pp.373~374 (2005)
  9. Young, C. B., "Anhedonia and general distress show dissociable ventromedial prefrontal cortex connectivity in major depressive disorder", Transl Psychiatry, 6, pp.e810~ (2016)
  10. Williams, L. M., "Precision psychiatry : a neural circuit taxonomy for depression and anxiety", Lancet Psychiatry, 3, pp.472~480 (2016)
  11. Hammen, C., "Stress and depression", Annu Rev Clin Psychol, 1, pp.293~319 (2005)
  12. Charney, D. S., "Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention", Sci STKE, 2004, pp.re5~ (2004)
  13. Koo, J. W., "Nuclear factor kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior", Proc Natl Acad Sci USA, 107, pp.2669~2674 (2010)
  14. Bondi, C. O., "Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment", Neuropsycho pharmacology, 33, pp.320~331 (2008)
  15. Wiborg, O., "Chronic mild stress for modeling anhedonia", Cell Tissue Res, 354, pp.155~169 (2013)
  16. Strekalova, T., "Measuring behavior in mice with chronic stress depression paradigm", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.348~361 (2010)
  17. Bagot, R. C., "Circuit-wide Transcriptional Profiling Reveals Brain Region Specific Gene Networks Regulating Depression Susceptibility", Neuron, 90, pp.969~983 (2016)
  18. Lorsch, Z. S., "Stress resilience is promoted by a Zfp189-driven transcriptional network in prefrontal cortex", Nat Neurosci, 22, pp.1413~1423 (2019)
  19. Krishnan, V., "Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions", Cell, 131, pp.391~404 (2007)
  20. Labonté, B., "Sex-specific transcriptional signatures in human depression", Nat Med, 23, pp.1102~1111 (2017)
  21. Maschietto, M., "Co-expression network of neural-differentiation genes shows specific pattern in schizophrenia", BMC Med Genomics, 8, pp.23~ (2015)
  22. Vician, L., "Synaptotagmin IV is an immediate early gene induced by depo larization in PC12 cells and in brain", Proc Natl Acad Sci USA, 92, pp.2164~2168 (1995)
  23. Littleton, J. T., "Synaptic function modulated by changes in the ratio of synaptotagmin I and IV", Nature, 400, pp.757~760 (1999)
  24. Johnson, S. L., "Synaptotagmin IV determines the linear Ca2+ dependence of vesicle fusion at auditory ribbon synapses", Nat Neurosci, 13, pp.45~52 (2010)
  25. Dean, C., "Synaptotagmin-IV modulates synaptic function and long-term potentiation by regulating BDNF release", Nat Neurosci, 12, pp.767~776 (2009)
  26. Wong, Y. H., "Activity-dependent BDNF release via endocytic pathways is regulated by synaptotagmin-6 and complexin", Proc Natl Acad Sci USA, 112, pp.E4475~E4484 (2015)
  27. Duman, R. S., "Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants", Eur J Neurosci, 53, pp.126~139 (2021)
  28. Sen, S., "Serum brain-derived neurotrophic factor, depression, and antidepressant medications : meta-analyses and implications", Biol Psychiatry, 64, pp.527~532 (2008)
  29. Tripp, A., "Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder", Am J Psychiatry, 169, pp.1194~1202 (2012)
  30. Lindholm, J. S., "Mice with altered BDNF signaling as models for mood disorders and antidepressant effects", Front Behav Neurosci, 8, pp.143~ (2014)
  31. Ghosal, S., "Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine", Biol Psychiatry, 83, pp.29~37 (2018)
  32. Fukumoto, K., "Activity-dependent brain-derived neurotrophic factor sig naling is required for the antidepressant actions of(2R, 6R)-hydroxynorketamine", Proc Natl Acad Sci USA, 116, pp.297~302 (2019)
  33. Deyama, S., "Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine", Pharmacol Biochem Behav, 188, pp.172837~ (2020)
  34. Guenthner, C. J., "Permanent genetic access to transiently active neurons via TRAP: targeted recombination in active populations", Neuron, 78, pp.773~784 (2013)
  35. Der-Avakian, A., "The neurobiology of anhedonia and other reward related deficits", Trends Neurosci, 35, pp.68~77 (2012)
  36. Kim, J., "Metabotropic Glutamate Receptor 5 in Amygdala Target Neurons Regulates Susceptibility to Chronic Social Stress", Biol Psychiatry, 92, pp.104~115 (2022)
  37. Zhang, G., "Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance", Neuron, 69, pp.523~535 (2011)
  38. Wang, Z., "Rat and Drosophila synaptotagmin 4 have opposite effects during SNARE-catalyzed membrane fusion", J Biol Chem, 285, pp.30759~30766 (2010)
  39. Kojima, M., "Journey of brain-derived neurotrophic factor : from intracellular trafficking to secretion", Cell Tissue Res, 382, pp.125~134 (2020)
  40. Mendez, J. A., "Somato dendritic dopamine release requires synaptotagmin 4 and 7 and the participation of voltage-gated calcium channels", J Biol Chem, 286, pp.23928~23937 (2011)
  41. Delignat-Lavaud, B., "Implication of synaptotagmins 4 and 7 in activity-dependent somatodendritic dopamine release in the ventral midbrain", Open Biol, 12, pp.210339~ (2022)
  42. Leal, G., "BDNF and Hippocampal Synaptic Plasticity", Vitam Horm, 104, pp.153~195 (2017)
  43. Teng, H. K., "ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin", J Neurosci, 25, pp.5455~5463 (2005)
  44. Pizzagalli, D. A., "Depression, stress, and anhedonia : toward a synthesis and inte grated model", Annu Rev Clin Psychol, 10, pp.393~423 (2014)
  45. Kim, J., "The Role of Glutamate Underlying Treatment-resistant Depression", Clin Psychopharmacol Neurosci, 21, pp.429~446 (2023)
  46. Chen, S., "A hypothalamic novelty signal modulates hippocampal memory", Nature, 586, pp.270~274 (2020)
  47. Zhao, Z., "Encoding of social novelty by sparse GABAergic neural ensembles in the prelimbic cortex", Sci Adv, 8, pp.eabo4884~ (2022)
  48. Girgenti, M. J., "Transcriptomic organization of the human brain in post traumatic stress disorder", Nat Neurosci, 24, pp.24~33 (2021)
  49. Lanz, T. A., "Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia : a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder", Transl Psychiatry, 9, pp.151~ (2019)
  50. Ferguson, G. D., "Reduced anxiety and depression like behavior in synaptotagmin IV(-", -)mice, 2004, pp.47, 604~611
  51. Aloyz, R., "Activity dependent activation of TrkB neurotrophin receptors in the adult CNS", Learn Mem, 6, pp.216~231 (1999)
  52. Sasi, M., "Neurobiology of local and intercellular BDNF signaling", Pflugers Arch, 469, pp.593~610 (2017)
  53. Zhang, Z., "a multifunctional regulator of peptidergic nerve terminals", Nat Neurosci, 12, pp.163~171 (2009)
  54. De La Garza, R. 2nd, "A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression", Brain Res, 1021, pp.209~218 (2004)
  55. Szczepanik, J. C., "Repeated Methylglyoxal Treatment Depletes Dopamine in the Prefrontal Cortex, and Causes Memory Impairment and Depressive-Like Behavior in Mice", Neurochem Res, 45, pp.354~370 (2020)
  56. Tanda, G., "Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?", Psycho pharmacology (Berl), 115, pp.285~288 (1994)
  57. Sabihi, S., "Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats", Psycho neuroendocrinology, 45, pp.31~42 (2014)
  58. Lu, J., "Exercise ameliorates depression-like behavior and increases hippo campal BDNF level in ovariectomized rats", Neurosci Lett, 573, pp.13~18 (2014)
  59. Kiss, A., "17beta-estradiol replacement in young, adult and middle-aged female ovariectomized rats promotes improvement of spatial reference memory and an antidepressant effect and alters monoamines and BDNF levels in mem ory-and depression-related brain areas", Behav Brain Res, 227, pp.100~108 (2012)
  60. Pemberton, K., "Differential Effects of the G-Protein-Coupled Estrogen Receptor (GPER) on Rat Embryonic (E18) Hippocampal and Cortical Neurons", eNeuro, 9 (2022)
  61. Göcz, B., "Estrogen differentially regulates transcriptional landscapes of preoptic and arcuate kisspeptin neuron populations", Front Endocrinol (Lausanne), 13, pp.960769~ (2022)
  62. Calati, R., "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients", Prog Neuropsychopharmacol Biol Psychiatry, 44, pp.271~278 (2013)
  63. Calabrò, M., "Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder : CACNA1C, CHRNA1, and MAPK1", Neuropsychobiology, 74, pp.159~168 (2016)
  64. Eriksson, T. M., "Emotional memory impairments in a genetic rat model of depression : involvement of 5-HT", MEK, Mol Psychiatry, pp.2012, 17[DOI]
  65. Ikeda, M., "Genome-wide environment interaction between depressive state and stressful life events", J Clin Psychiatry, 77, pp.e29~e30 (2016)
  66. Winham, S. J., "Bipolar disorder with comorbid binge eating history : a genome-wide association study implicates APOB", J Affect Disord, 165, pp.151~158 (2014)
  67. Ramos-da-Silva, L., "Molecular Mechanisms Associated with Antidepressant Treatment on Major Depression", Complex Psychiatry, 7, pp.49~59 (2021)
  68. Ashley-Koch, A. E., "Genome-wide association study of posttraumatic stress disorder in a cohort of Iraq-Afghanistan era veterans", J Affect Disord, 184, pp.225~234 (2015)

관련 논문AI추천

Activity in the dorsal hippocampus-mPFC circuit modulates stress-coping strategies during inescapable stress김명환, 김상정, Chung Geehoon, Song Woo Seok, Yoon Sang Ho생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Acute Stress and Chronic Stress Change Brain-Derived Neurotrophic Factor (BDNF) and Tyrosine Kinase- Coupled Receptor (TrkB) Expression in Both Young and Aged Rat HippocampusBang-ping Yuan, Fang Pan, Shou-Sen Shi, Shu-hong Shao, Zun-Ling Li연세대학교의과대학 · Yonsei Medical Journal2010 · 제51권 제5호Role of phospholipase Cη1 in lateral habenula astrocytes in depressive-like behavior in miceChoi Hoon-seong, Hong Eun-bin, Kang Miseon, Kim Beomsue, Kim Jae-Ick, Kim Jeongyeon, Lee Ho, Lee Jiyoung, Nam Min-ho, Song Sukwoon, Suh Pann-Ghill, Yang Yong Ryoul생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권 ErbB4 precludes the occurrence of PTSD-like fear responses by supporting the bimodal activity of the central amygdalaChoi Soo-Hee, Jeong Min-Jae, Jung Jung Hoon, Kang Sumin, Kim Hyun Jin, Kim Joung-Hun, Koo Noah, Lee Hyun-Yong, Park Kyunghyun, Pyo Jung Hyun, Sung Kibong, Yoo Jong-Yeon, Yoo Taesik생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment김용구, Bun-Hee Lee대한신경정신의학회 · PSYCHIATRY INVESTIGATION2010 · 제7권 제4호The Role of Glutamate Underlying Treatment-resistant DepressionJa Wook Koo, Jeongseop Kim, Seung-Hwan Lee, Tae-Eun Kim대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2023 · 제21권 제3호

이 간행물의 다른 논문 (218건)